EP Patent

EP4199980A1 — Injectable composition and use of said composition

Assigned to Innate Srl · Expires 2023-06-28 · 3y expired

What this patent protects

Injectable composition in hydrogel form, comprising water and micronized croscarmellose sodium. Method for preparing said injectable composition comprising mixing the components and heat treating the obtained composition at a temperature between 90°C and 150°C, preferably between…

USPTO Abstract

Injectable composition in hydrogel form, comprising water and micronized croscarmellose sodium. Method for preparing said injectable composition comprising mixing the components and heat treating the obtained composition at a temperature between 90°C and 150°C, preferably between 100°C and 130°C.

Drugs covered by this patent

Patent Metadata

Patent number
EP4199980A1
Jurisdiction
EP
Classification
—
Expires
2023-06-28
Drug substance claim
No
Drug product claim
No
Assignee
Innate Srl
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.